CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment

類似資料

• CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: Is clinical testing helpful?
  著者:: Singh, Mukesh, 等
  出版事項: (2012)
• The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention
  著者:: Liu, Guohua, 等
  出版事項: (2020)
• Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
  著者:: Zhuo, Zhong-ling, 等
  出版事項: (2018)
• Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
  著者:: Wang, Bin, 等
  出版事項: (2018)
• Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism
  著者:: SU, JUN-FENG, 等
  出版事項: (2015)